Compare Medtronic PLC (MDT) vs ON Holding AG (ONON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs ON Holding AG — how do they compare? Medtronic PLC trades at $82.89 (market cap $106.61B), while ON Holding AG trades at $37.2 (market cap $12.55B). The key difference: Medtronic PLC is far larger — about 8.5× ON Holding AG's market cap, and Medtronic PLC pays a 3.46% dividend while ON Holding AG pays none. Which is the better fit depends on your goals.
| MDT | ONON | |
|---|---|---|
Market Cap | $106.61B | $12.55B |
Sector | Health | Technology |
52-Week High | $105.35 | $53.21 |
52-Week Low | $73.75 | $31.88 |
Enterprise Value | $125.36B | $11.87B |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
ONON trades at $37.65, up 1.21% today, with a bearish technical signal from moving averages but neutral oscillators. The company shows strong profitability with a 63.88% gross margin and has beaten earnings estimates for three consecutive quarters. Revenue reached $3.01B in 2025, with net income of $203.70M. Analyst sentiment is overwhelmingly positive, with 76.92% recommending Buy.
The outlook remains favorable due to consistent earnings beats and projected revenue growth to $3.1B in 2026. Risks include high valuation multiples like a P/E of 40.14 and competitive pressures. The consensus price target of $47.33 suggests 25.7% upside, but investors should monitor execution against growth expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About ON Holding AG
ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →
